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Human renal fibroblasts modulate proximal tubule cell growth and
transport via the IGF-I axis. To determine the paracrine interactions
involved in the tubulointerstitial response to progressive renal disease, the
role of insulin-like growth factor-I (IGF-I) and its binding proteins
(IGFBP5) in in Vitro interactions between human proximal tubule cells
(PTC) and renal cortical fibroblasts (CF) were studied in primary cell
culture. PTC growth and transport were increased in the presence of
CF-conditioned media (CF-CM), as shown by increased thymidine incor-
poration, cellular protein content and sodium-hydrogen exchange (NHE)
activity, to 185 31% (P < 0.01), 150 18% (P < 0.05) and 195 27%
(P < 0.01) of the control values, respectively. IGF-I was produced by
cultured CF at a rate of 64.6 7.5 ng/mg protein/day. Exogenous IGF-I
applied to PTC provoked similar enhancement of growth and NHE
activity as CF-CM and the stimulatory effect of CF-CM was blocked by
specific immunoneutralization of IGF-I receptors. These receptors were
threefold more abundant on PTC basolateral versus apical membranes.
IGF binding proteins (IGFBP)-2 and IGFBP-3 were secreted by CF at
rates of 694 88 and 1769 45 ng/mg/day, with the release of IGFBF-3
being enhanced in the presence of PTC-CM (120.0 9.7% of control, P <
0.01). Moreover, the addition of CF-CM to FTC increased cell-associated
IGFBP-3 on FTC surfaces, without changes in IGF-I receptor numbers or
affinity and without changes in FTC mRNA for IGFBP-3. Des(1-3)IGF-I,
an analog that binds to the IGF-I receptor but not to IGFBPs, provided a
less potent stimulus for FTC growth compared with IGF-I, indicating that
cell-associated IGFBP-3 facilitates the action of IGF-I on FTC. The
results support important paracrine roles for both IGF-I and IGFBFs in
the interstitial regulation of proximal tubule growth and transport.
The ontogeny, growth and function of many epithelial tissues is
regulated by the adjacent stroma [1]. However, despite the fact
that over 60% of the outer proximal tubular surface is in direct
contact with the cortical interstitium [2], paracrine interactions
between mesenchymal and epithelial tissues within the kidney
have received little study to date. Montessano, Schaller and Orci
[3] have provided evidence that renal tubular cell growth and
differentiation are under the influence of factors produced by
fibroblasts by demonstrating that Madin-Darby canine kidney
(MDCK) cells undergo mitogenesis and tubulogenesis in the
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presence of lung and skin fibroblasts, even when the cell popula-
tions are not in direct contact. Since both lung and skin fibroblasts
are known to produce insulin-like growth factor-I (IGF-I) [4], a
peptide that exerts diverse effects on proximal tubule cell (PTC)
metabolism [5], growth [6] and transport [7], it is possible that
renal cortical fibroblasts (CF) may also modulate adjacent PTC
growth and function via the production of this cytokine.
Changes in intrarenal IGF-I have been shown to be important
in several adaptive and pathologic renal conditions, including
compensatory proximal tubular hypertrophy following nephron
loss, diabetic nephropathy and tubular epithelial repair following
toxic or ischemic insults [8—11]. More recently, it has been
appreciated that the functions of IGF-I within the kidney are
modulated by locally produced IGF binding proteins (IGFBPs)
[11]. The precise cells within the kidney responsible for synthesis
of the various components of the intra-renal IGF-IIIGFBP axis
are not fully defined [11]. However, renal interstitial fibroblasts
may well play a significant role in this axis as extrarenal fibroblasts
are known to produce both IGF-I and a variety of IGFBPs [4, 12,
13]. Hence, the aim of the present in vitro study was to examine
the paracrine IGF-I/IGFBP interactions between human CF and
PTC populations and their influence on PTC growth and trans-
port.
METHODS
Patients
Segments of macroscopically and histologically normal renal
cortex were obtained aseptically from adult human kidneys re-
moved surgically because of small (< 6 cm) renal adenocarcino-
mas (N = 7), pelviureteric transitional cell carcinoma (N = 4) or
benign angiomyolipoma (N = 1). The average patient age was
66.7 3.0 years and the male:female ratio was 7:5. Patients were
otherwise healthy and were on no medications. Informed consent
was obtained prior to each operative procedure, and the use of
human renal tissue for primary culture was reviewed and ap-
proved by the Royal North Shore Hospital Human Research
Ethics Committee.
Cell culture
The method for primary culture of human PTC is described in
detail elsewhere (14]. Primary cultures of renal cortical fibroblasts
were obtained by minor modifications of this method. Briefly,
renal cortical tissue was dissected from the medulla, minced,
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digested with collagenase (class 2, 383 U/mg; Worthington, Free-
hold, NJ, USA) and passed through a 100 gm mesh. Filtered
tissue was resuspended in 45% Percoll (Pharmacia, Uppsala,
Sweden) and separated into four distinct bands by isopyknic
ultracentrifugation. The lowermost band was removed for FTC
culture. The uppermost band was removed for renal cortical
fibroblast culture.
FTC were resuspended in serum-free, antibiotic-free, hormon-
ally-defined media, consisting of 1:1 (vol/vol) Dulbecco's modified
Eagle's media and Ham's F-12 (DMEM/F-12) (ICN Pharmaceu-
ticals Inc., Costa Mesa, CA, USA), supplemented with 5 1tg/ml
human transferrin (Sigma Chemical Co., St. Louis, MO, USA), 5
tg/ml (0.87 gM) bovine insulin (Sigma), 0.05 gsi hydrocortisone
(Sigma), 10 ng/ml (1.64 nM) epidermal growth factor (Collabora-
tive Research Inc., Bedford, MA, USA), 50 jiM prostaglandin E1
(Sigma), 50 n selenium (Sigma) and 5 M tri-iodothyronine
(Sigma). The tubular fragments were plated at a density of 1.5 mg
pellet/cm2 (approximately 5000 to 7000 fragments/cm2) in 75 cm2
flasks (Corning, New York, NY, USA). Media were changed
every 48 hours. The cells were incubated in humidified 95%
air/5% CO2 at 37°C and were subcultured at near-confluence
using seeding densities of 4000 cells/cm2. Such cells were desig-
nated passage 1. Cytologic examination of FTC preparations from
all donors failed to reveal any evidence of cellular atypia. The
ultrastructural, growth and transport characteristics of these cells
and their responses to hormonal and cytokine stimulation have
been previously studied in this laboratory and found to reproduc-
ibly exhibit the features of FTC in vivo [14].
Renal cortical fibroblasts (CF) were resuspended in antibiotic-
free DMEM/F-12 containing 10% fetal calf serum (Trace Bio-
sciences, Sydney, Australia) and were seeded at an initial density
of 2.25 mg pellet/cm2. Subculture at confluence was subsequently
performed using a seeding density of 7000 cells/cm2. Because
doubling times were greater for CF than for FTC, the higher
seeding densities used in the former group allowed the synchro-
nization of the attainment of confluence in both populations at
approximately five days after plating.
Cortical fibroblast characterization
The cellular viabilities of CF cultures were confirmed by Trypan
blue exclusion [7]. Morphologic examination revealed pure pop-
ulations of mitotic fibroblasts characterized by typical spindle or
epithelioid morphologies (Fig. 1). Although PTC contamination
accounted for up to 15% of cells in confluent primary cultures,
fibroblasts rapidly overgrew PTC in the presence of 10% fetal calf
serum, such that the numbers of FTC in subsequent passages were
negligible. This was confirmed by uniform positive immunohisto-
chemical staining for vimentin, an intermediate filament marker
of mesenchyme [15], and negative staining for cytokeratin, an
epithelial cell marker [15]. Mesangial cell contamination was
excluded by negative staining for desmin (a marker of glomerular
mesangial cells both in vitro and in vivo) [15]. Alpha-smooth
muscle aetin, a marker of pathologically activated fibroblasts
(myofibroblasts) [16], could not be demonstrated in CF by either
electron microscopy or immunohistochemistry. Confirmation of
the renal cortical origin of fibroblasts was based on the known
differential localization of S'-ectocytonucleotidase (5NT) to cor-
tical, but not medullary, fibroblasts [17]. Cells from the first four
passages uniformly stained positive for SNT, as determined by the
lead precipitation technique of Wachstein and Meisel [18].
Experimental protocol
The role of JOE-I in paracrine CF-FTC interactions was
evaluated by demonstrating that: (a) CF produce IGF-I and
IGFBPs, (b) FTC express specific receptors for JOE-I, (c) ICE-I
action on PTC is modulated by cell-associated IOFBPs, and (d)
PTC secrete soluble factors into conditioned media which in turn
regulate the production of IOF-I and/or ICFBFs by CF. Further
experiments were designed to determine whether exposure of
PTC to CF-derived IGF-I in either conditioned media or cocul-
ture experiments modulated FTC growth and sodium-hydrogen
exchange (NHE) activity and whether these effects could be
reproduced by exogenous IGF-I and blocked by a specific, neu-
tralizing anti-IGF-1-receptor antibody. The effect of native
IGFBFs on IGF-l-stimulated PTC growth was evaluated by
comparing the relative actions of exogenous bE-I and an JOE-I
analog with markedly reduced affinity for IOFBFs.
All experiments were performed on quiescent, confluent, pas-
sage 2 PTC and CF. Cells were made quiescent by two washes
followed by incubation for 24 hours in basic media (DMEM/F-12
containing 5 jig/ml human transferrin). FTC- or CF-conditioned
media were obtained by incubating quiescent FTC or CF for 24
hours in 8 ml of fresh basic media in 25 cm2 flasks. The media
were then collected and centrifuged to remove cellular material.
Measurement of insulin-like growth factor binding protein
production by cortical fibroblasts
CF-conditioned media (CF-CM) were initially screened for the
presence of IGFBPs by ligand blot analysis, as described previ-
ously [13]. Ligand blots revealed a major band of relative molec-
ular weight (Mr) = 42000 and an additional band of Mr = 32000.
These bands were identified as IGFBP-3 and IOFBP-2, respec-
tively, on the basis of Mr and immunoblotting with specific
antisera (not shown). Quantitative measurement of JOFBP-3 and
IGFBP-2 production was performed by assaying media condi-
tioned for 4, 24 and 48 hours by CF in specific IOFBF-3 and
IGFBP-2 radioimmunoassays (RIA5). The methods for these
RIAs are described in detail elsewhere [19, 20].
Measurement of insulin-like growth factor-I production by
cortical fibroblasts
IGFBPs were dissociated from IGF-1 and were eliminated from
CF-CM samples using the Bio-Spin P-ID separation method
described by Mohan and Baylink [21]. IGF-I concentrations were
then measured by assaying 50 Itl in duplicate in a previously
described RIA [22]. The absence of interfering IGFBPs from the
fractions pooled for ICE-I measurements was confirmed by ligand
blot analysis and IOF-1 recovery rates exceeded 96%. Maximum
specific binding of JOE-I tracer to antibody exceeded 30%. The
detection limits of the assay were 0.1 to 50 ng/ml. Cross reactivity
of IOF-Il in this assay was negligible. The intra- and interassay
coefficients of variation (cv) were less than 5% and 10%, respec-
tively.
Detection of IGF-I receptors on proximal tubule cells
['251/-IGF-J binding. Using the chloramine-T method, 5 jig of
recombinant human tGF-I (Kabi Peptide Hormones, Stockholm,
Sweden) was iodinated with 1 mCi 125!. The specific activity of
['I]-IGF-1 prepared in this fashion was approximately 200
jiCi/jig. In order to independently evaluate the presence of IGF-I
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Fig. 1. (A) Typical confluent monolayer of human cortical fibroblasts (x500 magnification). The cells display typical plump, fusiform or
stcllate morphologies with smooth overlying surfaces and thin, sometimes ramified processes that contact adjacent cells via nexi. (B)
Typical confluent monolayer of human proximal tubule cells (x500 magnification), displaying the characteristic "cobblestone" appearance.
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binding sites on apical and basolateral membranes, PTC were
grown on membrane filter inserts. After three washes with ice-
cold PBS, the apical or basolateral aspects of PTC monolayers
were respectively incubated in 200 .d or 300 /Ll basic media,
containing [1251]-IGF-I (200,000 cpm) in the presence or absence
of various concentrations of unlabeled IGF-I (10—12 M to i0 M).
Basic media was added to the contralateral compartments. All
incubations were at 4°C for two hours. Media were then collected
and further radioligand binding to PTC monolayers was stopped
by three washes with ice-cold PBS. Cells were solubilized in 200 l
0.2 M NaOH and were subsequently neutralized with an equiva-
lent volume of 0.2 M HCI. Aliquots were submitted for protein
determinations (Bio-Rad protein assay kit II; Bio-Rad, Hercules,
CA, USA) and gamma counting. Nonspecific binding, defined as
the amount of bound [1251]-IGF-I in the presence of an excess of
unlabeled IGF-I (1 ILM), was subtracted from total binding to
determine specific IGF-I binding. ['251]-IGF-I degradation, deter-
mined by precipitation of 50 jJ media with an equivalent volume
of 20% trichloroacetic acid (TCA), was uniformly less than 10%
under the above incubation conditions. Transepithelial leakage of
['251]-IGF-I was also measured during each study and was consis-
tently less than 2%.
Affinity cross-linking. Proximal tubule cells (PTC) were washed
three times with cold PBS and then incubated with ['251]-IGF-I
(106 cpm) for two hours at 4°C in the presence or absence of
10_6 M unlabeled IGF-I, 10_6 M insulin or 5 Lg/ml mouse
monoclonal anti-IGF-I receptor antibody (aIR; Santa Cruz Bio-
technology Inc., Santa Cruz, CA, USA). After a further three
washes with PBS, IGF-I was covalently cross-linked to its receptor
by exposing PTC for 15 minutes at 4°C to 500 1d basic media
containing 0.25 mtvi disuccinimidyl suberate (Pierce Biochemicals,
Rockford, IL, USA). The reaction was stopped by the addition of
1 ml 1 mivi ethylenediaminetetra-acetic acid (EDTA)/10 mM
Tris-HCI, pH 7.5, and the wells washed a further three times with
PBS. Monolayers were solubilized in 100 fd fourfold concentrated
Laemmli buffer (0.04 M Tris, 4% sodium dodecyl sulphate, 40%
glycerol, 0.01% bromophenol blue, 100mM dithiothreitol, pH 6.8)
and separated by 7.5% SDS-PAGE under reducing conditions.
Prestained molecular weight standards (Kaleidoscope, Bio-Rad)
were processed in parallel. Gels were stained for three hours at
37°C with 0.1% Coomassie Brilliant Blue R-250 (Bio-Rad), 25%
isopropanol and 10% acetic acid. After destaining for two hours at
37°C with 25% methanol, 10% acetic acid and 3% glycerol, the
gels were dried and exposed to Hyperfilm-MP (Amersham) for 14
days at —80°C. Autoradiographic bands were quantitated by
densitometry using the Kodak electrophoresis documentation and
analysis system (Kodak Scientific Imaging Systems, Rochester,
NY, USA).
To determine whether CF modulate IGF-I binding sites on
PTC, the latter were also preincubated with CF-CM for 24 hours
prior to radioligand binding and affinity labeling studies.
Proximal tubule cell feedback on cortical Ilbi-oblast production
of IGF-I and IGFBPs
To determine whether PTC exerted feedback effects on the
secretion of IGF-I and/or IGFBPs by CF, PTC-conditioned media
(PTC-CM) or basic media were placed directly onto the CF
monolayers. After 24 hours, the media were collected, centrifuged
to remove any cellular material and assayed as described above.
Assessment of the growth effects of cortical fibroblasts on
proximal tubule cells
Conditioned media experiments. Cellular protein content, an
index of cell hypertrophy [23], and tritiated thymidine incorpora-
tion, an index of DNA synthesis and hence hyperplasia [23], were
measured in PTC exposed for 24 hours to CF-CM, using previ-
ously outlined methods [7]. PTC incubated in basic media served
as controls. The size of CF-derived soluble growth factors was
inferred by evaluating the growth response of PTC to dialyzed
CF-CM. CF-CM were initially dialyzed against fresh basic media
using a 6 kDa cut-off dialysis membrane (Selby Anax, Sydney,
Australia) prior to incubation with PTC. PTC were also exposed
to PTC-CM to ensure that the effects of CF-CM were cell-type
specific.
Coculture experiments. Coculture experiments were performed
to determine whether any growth effects exerted by CF-derived
soluble factors on PTC were subject to feedback regulation and to
assess the potentially different effects of sustained low level
release of growth factors by coincubated cells. Confluent mono-
layers of PTC grown on porous membrane filter inserts (Millicell-
CM, 0.4 j.m, 12 mm diameter; Millipore, Bedford, MA, USA)
were placed over confluent CF monolayers grown in 24-well
culture plates (Nunc, Roskilde, Denmark). Both cell populations
were incubated together for 24 hours in basic media. Proximal
tubule cells grown on inserts in 24-well plates without fibroblasts
served as controls. Cellular protein content and thymidine incor-
poration were subsequently measured.
Assessment of the effects of cortical fibroblasts on proximal
tubule cell sodium-hydrogen exchange activity
Sodium-hydrogen exchange (NHE) activities were measured in
PTC monolayers incubated in basic media or CF-CM for 8, 16 or
24 hours. Intracellular pH (pH1) recovery rates and H efflux
rates from cells following isosmotic, 20 m'vi NH4C1 prepulses were
measured in the presence or absence of 10 j.M ethylisopro-
pylamiloride (EIPA) by 2',7'-bis(2 carboxyethyl)-5 [6-carboxy-
fluorescein (BCECF) microspectrofluorimetry, as described pre-
viously [7]. NHE activity was defined as the component of H
efflux that was Natdependent and inhibited by EIPA.
Inhibition of cortical fibroblast conditioned medium effects on
PTC growth and NHE activity by IGF-I receptor
immunoneutralization
To determine whether the effects of CF-CM on PTC growth
and NHE activity could be inhibited by blocking the action of
IGF-I at the IGF-J receptor, PTC were incubated in basic media
or CF-CM, in the presence or absence of 5 j.g/ml aIR, for 24
hours. Growth parameters and NHE activities were then mea-
sured as described above. A total of 5 .g/ml aIR was initially
confirmed in pilot studies to abolish the growth effects of 50 ng/rnl
IGF-I on PTC (data not shown).
Assessment of the effects of exogenous IGF-I and des(1-3)IGF-l
on proximal tubule cell growth
The role of PTC-associated IGFBPs in regulating the action of
TGF-I on PTC was examined by comparing the concentration-
response effects of exogenous IGF-l and des(1-3)IGF-I (Genen-
tech, San Francisco, CA, USA) on PTC thymidine incorporation.
Des(1-3)IGF-I is an IGF-1 analogue that binds to the IGF-l
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receptor with a similar affinity compared to IGF-1, but has
markedly reduced binding to IGFBPs [8]. Thus, any difference in
the relative actions of IGF-I and des(1-3)IGF-I reflects the
modulatoiy effects of local IGFBPs.
IGFBP-3 mRNA analysis
Confluent, quiescent CF were incubated in PTC-CM or basic
media for 24 hours. Total RNA was extracted from cell cultures by
the guanidinium thiocyanate method [24] and quantified by
spectrophotornetric readings at Absorbance260. For Northern blot
analysis, RNA was denatured, diluted in sample buffer (50%
deionized formamide, 6.6% formaldehyde, 1 x MOPS and 5.1
jxg/ml ethidium bromide) and fractionated by electrophoresis
through a 1.4% agarose gel (20 xg per lane). To confirm that
similar amounts of RNA were loaded and to assess the integrity of
RNA, ribosomal RNAs (28S and 18S) were visualized with UV
transillumination. RNA was then transferred by capillary blotting
to Hybond N membranes (Amersham) and fixed by baking at
80°C for two hours. Membranes were prehybridized at 42°C for
two hours with hybidization buffer (50% deionized formamide,
5 >< Denhardt's solution, 5 x SSPE, 7% SDS and 100 jig/mI
denatured salmon sperm DNA) and were then hybridized at 42°C
overnight with fresh buffer containing 30 X 106 cpm of a
32P-labeled, human IGFBP-3 eDNA probe (kindly provided by
Dr. S. Shimasaki, Scripps Institute, La Jolla, CA, USA). The blots
were washed in I X SSC, 0.1% SDS at 42°C for 15 minutes and in
0.1 x SSC, 1% SDS at 42°C for 15 minutes. After washing, the
membranes were exposed to Hyperfilm-MP (Amersham) between
two intensifying screens at —80°C. The nylon membrane was then
stripped by boiling in 0.1 X SSC solution containing 0.25% SDS
for 60 minutes and then rehybridized with an 18S eDNA probe (a
kind gift from D. Denhardt, New Jersey, USA). Autoradiographic
bands were quantitated by densitometry. IGFBP-3 mRNA density
was corrected for the densitometric intensity of 18S for each
sample. For the purposes of comparison, this ratio was set at unity
for control samples and other lanes on the same gel were
expressed as a fold increase over this value.
Similarly, Northern blot analysis of IGFBP-3 mRNA levels was
performed in PTC exposed to CF-CM or basic media for 24 hours,
in order to determine the contribution of PTC IGFBP-3 produc-
tion to PTC surface-bound IGFBP-3.
Statistical analysis
All studies were performed in triplicate from PTC cultures
obtained from 4 to 10 separate human donors. Normal distribu-
tion of all data were confirmed by the Kolmogorov-Smirnov test.
Results are expressed as mean SEM or as median (interquartile
range), depending on the distribution of data. Statistical differ-
ences between groups were assessed by Student's t-test (or
Mann-Whitney U-test for non-parametric analyses) or by one-way
analysis of variance (ANOVA), depending on the number of
comparisons being made. Pairwise multiple comparisons were
made by Fisher's protected least significant differences test. IGF-I
binding data were analyzed by Scatchard analysis [25]. Analyses
were performed using the software package, Statview version 4.5
(Abacus Concepts Inc., Berkeley, CA, USA). P values less than
0.05 were considered significant.
Fig. 2. Time courses for the release of IGFBP-2 (A) and IGFBP-3 (•) by
cortical fibroblasts (CE) into culture media. Confluent, quiescent CF were
incubated for the indicated time periods in basic media, which were then
collected and assayed by specific IGFBP-2 and IGFBP-3 RIAs. Simple
regression analyses yielded straight lines for IGFBP-2 (y = 28.9x — 36.0,
= 0.969, P < 0.0001) and IGFBP-3 (y = 64.9x + 31.6, r2 = 0.999, P <
0.0001).
RESULTS
Cortical fibroblasts produce IGF-I, IGFBP-2 and IGFBP-3
IGFBP-3 and IGFBP-2 were secreted into media by CF in a
linear fashion during the first 48 hours (Fig. 2). CF-CM contained
3.9 0.5 ng/ml IGF-I (N = 18) at 24 hours, which translated into
a secretion rate of 64.6 7.5 ng/mg protein/day or 42.6 5.0
ng/106 cells/day.
In contrast, IGF-1 and IGFBPs were not detectable in PTC-
CM.
Proximal tubule cells predominantly express basolateral IGF-I
receptors and exhibit cell-associated IGFBP-3
Scatchard transformation of the equilibrium radiolabeled IGF-I
binding data for both apical and basolateral membranes revealed
considerable asymmetry of IGF-I binding with the maximum
specific binding capacities for apical membranes (53 2 fmol/mg
protein or 18,000 1,000 binding sites/cell) being several-fold
lower than for basolateral membranes (171 6 fmol/mg protein
or 56,000 2,000 binding sites/cell; Fig. 3). The dissociation
constants were similar for the two regions (1.26 n vs. 1.31 nrvi,
respectively). Over the two-hour time period, 6.2 3.0% and
5.3 1.9% of apically and basolaterally added [1251]-IGF-I were
degraded (P = not significant).
Affinity cross-linking experiments confirmed that human PTC
expressed an ['251]-IGF-I binding component with Mr 135,000 Da,
consistent with the IGF-I receptor alpha-subunit (Fig. 4). Binding
at this site was completely blocked by 10—6 M unlabeled IGF-I and
by 5 jig/mI aIR. A second band (Mr 50,000) was identified as
cell-associated IGFBP-3 on the basis of immunoblotting with a
previously described, specific rabbit polyclonal IGFBP-3 antibody
directed against human IGFBP-3 [19] (results not shown). Radio-
ligand binding at this site was inhibited by 10—6 M unlabeled
IGF-I, but not by aIR. Insulin, which exhibits less than 1%
cross-reactivity with the IGF-I receptor and does not bind to
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Fig. 3. Scatchard plots of ['251J-IGF-I binding to the apical (0) and
basolateral (•) membranes of human proximal tubule cells (PTC). PTC
monolayers grown on porous membrane inserts were incubated for two
hours at 4°C in media containing ['251]-IGF-I, in the presence or absence
of various concentrations of unlabeled IGF-I. Scatchard transformation
yielded straight lines (basolateral,y = —2.649 X 10x + 0.046, r2 = 0.99,
P < 0.01; apical, y = —2.737 X 10x + 0.015, r2 = 0.98, P < 0.01).
IGFBPs, resulted in partial inhibition of ['251]-IGF-I binding to
the Mr 135,000 band at a concentration of 10—6 M, but did not
alter binding at the Mr 50,000 site. Following preincubation of
PTC with CF-CM for 24 hours, the intensity of the Mr 50,000 band
was increased by a median value of 3.9-fold (interquartile range
1.3 to 10.7, N = 6,P < 0.05), whereas that of the Mr 135,000 site
was unchanged (median 1.0-fold, interquartile range 0.9 to 1.1,
N = 6, P not significant).
Proximal tubule cells exert feedback effects on cortical
fibroblast release of IGFBP-3
Cortical fibroblasts exposed to PTC-CM for 24 hours secreted
comparable amounts of IGF-I compared with controls (3.9 0.5
vs. 3.9 0.4 ng/ml, N = 18, P = NS). IGFBP-2 concentrations
were also not significantly different between the two groups (6.3
2.0vs. 5.9 1.9 ng/ml, respectively, N = 30). However, IGFBP-3
levels were increased in CF incubated in PTC-CM relative to
controls (124.6 9,0 vs. 91.2 6.8 ng/ml, respectively, N = 30,
P < 0.01). Measured IGFBP-3 secretion rates were 1162 94 and
969 59 ng/mg protein/day, respectively (P < 0.05).
Cortical fibroblasts stimulate proximal tubule cell growth
Proximal tubule cells cocultured with CF (N 24) or exposed
to CF-CM (N = 30) exhibited both increased cellular protein
content and increased thymidine incorporation (Fig. 5). Dialysis
of CF-CM prior to incubation with PTC (N = 30) did not modilS'
the growth-promoting effects of CF-CM on PTC. Conversely,
PTC incubated for 24 hours in PTC-CM (N = 24) showed no
appreciable difference in growth parameters compared with con-
trols.
Cortical fibroblasts stimulate proximal tubule cell
sodium-hydrogen exchange activity
The resting pH of PTC exposed to CF-CM for 24 hours was
significantly more alkaline than that of controls (7.14 0.03 vs.
6.96 0.03, respectively, N = 54, P < 0.0001). Following acid
loading, the EIPA-sensitive pH recovery and H effiux rates were
also increased in CF-stimulated PTC (0.064 0.007 U/mm and
10.45 1.42 mM/mm, respectively) compared with control PTC
(0.036 0.006 U/mm, P < 0.05 and 5.35 0.91 mM/mm, P < 0.01,
respectively). Time course studies indicated that the onset of
stimulation of PTC NHE activity by CF-CM was between S and 16
hours (Fig. 6).
IGF-I receptor immunoneutralization inhibits the effects of
CF-CM on PTC growth and NHE activity
Although basic media containing aIR antibody had no intrinsic
effect on PTC growth or NHE activity, the antibody completely
blocked the stimulatory effects of CF-CM on PTC EIPA-sensitive
H efflux (Fig. 6), protein content (Fig. 7) and thymidine
incorporation (Fig. 7). This confirmed that augmentation of both
PTC growth and transport by CF was mediated via IGF-I.
Proximal tubule cell-associated IGFBP-3 facilitates the effects
of IGF-I on PTC growth
Des(1-3)IGF-I, an IGF-I analog with markedly reduced binding
affinity for IGFBPs, was significantly less potent than IGF-I with
respect to augmentation of PTC thymidine incorporation (Fig. 8).
The maximum stimulation of DNA synthesis by the two peptides
was comparable (137 20% vs. 140 12% of control, respec-
tively).
IGFBP-3 mRNA expression is unaltered in cortical fibroblasts
by PTC-CM
Human CF and PTC both expressed significant amounts of
IGFBP-3 mRNA (Fig. 9). Incubation of CF in PTC-CM for
24 hours, which stimulated CF secretion of immunoreactive
IGFBP-3, was associated with a nonsignificant increase in the
IGFBP-3 mRNA/18S RNA ratio compared with controls (median
1.2-fold, interquartile range 1.0 to 1.6, N = 8, P = 0.07).
Conversely, PTC incubated in CF-CM for 24 hours also did not
significantly alter their IGFBP-3 mRNA expression compared
with controls (median 0.9, interquartile range 0.5 to 1.1), despite
the significant increase in PTC-associatcd IGFBP-3 demonstrated
by affinity labeling studies.
DISCUSSION
As histological changes in the tuhulointerstitial environment
are a major determinant of renal disease progression, even where
there is primary glomerular injury [26], the pathogenesis of the
observed heterogeneous areas of tubular atrophy and hypertrophy
is the subject of current investigation in a number of laboratories.
The present study demonstrates reciprocal paracrine regulation of
human proximal tubule cell (PTC) growth and transport by
renal cortical fibroblasts (CF) in vitro, which is mediated by the
IGF-l/IGFBP axis. Specifically, we have demonstrated that CF
secrete IGF-I, IIJFBP-2 and IGFBP-3, and that the secretion of
IGFBP-3 is subject to feedback regulation by soluble factors
released by PTC. PTC, which have an abundance of IGF-l binding
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Fig. 4. Autoradiograph of ['251]-IGF-I cross-linked to IGF-I receptors on confluent, quiescent, human proximal tubule cells (PTC) incubated for 24
hours in basic media (control, lanes ito 8) or cortical fibroblast (CF).conditioned media (CF-CM, lanes 9 to 13). Competition with unlabeled IGF-I
(1 jiM, lanes 3, 4, ii, 12), unlabeled insulin (1 JiM, lanes 5, 6, 13) or aIR (5 jig/mI, lanes 7, 8) is shown. The migration positions of molecular weight
standards (kDa) are indicated on the left.
sites on their basolateral or interstitial aspects, respond to the
presence of CF-CM with augmented growth and transport of Na
and H. As these effects are blocked by specific JGF-I receptor
immunoneutralization, a role of CF-secreted IGF-T is likely.
Moreover, PTC-associated IGFBP-3, which is increased in the
presence of CF, serves to further facilitate the stimulatory effects
of CF-derived IGF-T on PTC. Since we have previously validated
the integrity of this experimental system in reproducing the
characteristics of normal human PTC and CF [14], it is likely that
a paracrine relationship exists between these cells in vivo and may
be important in the regulation of tubulointerstitial homeostasis.
Previous evidence has suggested that the IGF-T/1GFBP axis is
modified in models of renal hypertrophy associated intimately
with renal disease [10, 27, 28]. Our results suggest that IGF-I
production by CF results in proximal tubular hypertrophy, in-
creased sodium transport and hypermetabolism, which have been
independently implicated in the pathogenesis of experimental
renal scarring [291. Importantly, the role of IGFBPs has previously
been unclear, as although cell-association of an IGFBP, possibly
IGFBP-3, has been demonstrated in vivo in the hypertrophying
kidneys of rats with diabetic nephropathy [28], IGFBPs have been
variously reported to either potentiate [30, 311 or inhibit [31] the
actions of IGF-I, depending on species and experimental condi-
tions. Our results clearly confirm that the actions of IGF-l were
facilitated by human PTC-associated IGFBPs, and establish their
importance in the regulation of the human tubulointerstitial
growth response.
Prior studies have suggested that glomerular mesangial and
cortical collecting duct cells are the primary renal sites of produc-
tion of IGF-I [11, 321. However, with the measured rate of IGF-I
synthesis by CF in the present study (42.6 4.95 ng/106 cells/day)
being similar to that reported for cortical collecting duct cells
(48.9 52 ng/106 cells) [33] and much higher than observed
production rates by mesangial cells (-- 6 ng/106 cells/day) [32], our
finding indicates that IGF-I secretion by CF is physiologically
significant. Although IGF-I produced by CF may act in an
autocrine fashion, the close proximity of CF to PTC in vivo
suggests that CF may constitute an important paracrine source of
IGF-I for the human proximal tubule.
Our hypothesis that a functionally significant IGF-I paracrine
system exists between neighboring CF and PTC is supported by
the findings that PTC express IGF-I receptors and that occupancy
of these receptors by CF-derived IGF-i induces biological re-
sponses with regards to both growth and transport. The affinities
and maximum specific binding capacities of apical and basolateral
membranes for IGF-I in the present study are comparable with
those reported for rat and canine PTC [34, 351, although no
previous studies in human tissue are available. As with all other
animal PTC studied, human PTC exhibit an asymmetrical distri-
bution of LGF-I receptors, which are predominantly located on
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Fig. 5. Cellular protein contents and thymidine uptakes in confluent
proximal tubule cells (PTC) exposed for 24 hours to cortical fibroblasts
(CF)-conditioned media (CF-CM, N, N = 30), dialyzed CF-CM (; N =
30), cocultured CF (; N = 24) or PTC-conditioned media (PTC-CM; L;;
N = 24). Results are expressed as a percentage of controls (cells incubated
in basic media alone). *P < 0.05 versus control, < 0.01 versus control.
BM CF-CM CF-CM CF-CM CF-CM
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Fig. 6. Time course for stimulation of proximal tubule cell (PTC) sodi-
um-hydrogen exchange (NHE) activity by cortical fibroblasts (CF)-
conditioned media (CF-CM) and its inhibition by LGF-I receptor immu-
noneutralization. Confluent PTC were exposed to basic media (BM); to
CF-CM for 8, 16 or 24 hours (CF-CM 8 hr, CF-CM 16 hr and CF-CM 24
hr, respectively); or to CF-CM containing 5 g/ml cxlR for 24 hours
(CF-CM+alR). NIlE activity was measured as the component of H
efflux following cellular acidification which was inhibited by 10 LM ETPA.
*D < 0.05 versus BM amid CF-CM+ aIR.
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Fig. 7. Effect of IGF-I receptor immunoneutralization on growth effects
of cortical fibroblasts (CF)-conditioned media (CF-CM) on proximal
tubule cells (PTC). Confluent, quiescent PTC were incubated for 24 hours
in CF-CM alone (CF-CM; •; N = 30), in CF-CM plus 5 jLg/ml aIR(CF-CM+aIR, N = 30), or in CF-CM plus 5 jig/mI mouse non-
immune globulin (CF-CM+MNTG, E; N = 30). Cellular protein content
and thymidine incorporation were then measured. Results are expressed
as percentages of controls (basic media alone). *p < 0.05 versus control,
#P < 0.05 versus CF-CM.
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Fig. 8. Comparison of effects of IGF-l (E) and des(1-3)IGF-I (•) on
proximal tubule cell (P'I'C) DNA synthesis. Confluent, quiescent FTC
were incubated for 24 hours in serum-free media containing various
concentrations of IGF-J or des [l-3}IGF-I. Results are normalized against
values for controls (vehicle alone) and represent the mean SEM of 6
experiments in triplicate.
the presentation of a single bolus of endogenous IGF-I in CF-CM,
Alternatively, a positive feedback loop may exist between CF and
PTC in coculture. The key role of IGF-T in mediating the
stimulation of FTC DNA synthesis, cellular hypertrophy and
NHE activity by CF-CM is confirmed by the fact that co-
incubation with blocking anti-IGF-l receptor antibody abrogates
these effects. This is in keeping with in vivo studies, which have
found that experimentally induced renal growth is preceded by
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hasolateral membranes. Since these hasolateral membranes lie in
close contact with the renal cortical interstitium in vivo, the
predominance of IGF-I receptors in these regions may underline
the importance of CF as a source of endogenous IGF-l,
Exposure of PTC to CF-CM additionally results in stimulation
of PTC growth and NHE activity, a finding that is reproduced by
the administration of exogenous IGF-l [7J. The stimulation of
PTC growth is even greater when PTC are eocultured with CF.
This augmentation may reflect a difference in PTC response to
the sustained release of IGF-l by CF in coculture, as opposed to
w'4. t1T
I-
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Fig. 9. Northern blot analysis of IGFBP-3 mRNA in proximal tubule
cells (PTC; lanes 1 and 2) and cortical fibroblasts (CF; lanes 3 and 4).
PTC were incubated for 24 hours in basic media (lane 1) or CF-CM (lane
2). CF were incubated for 24 hours in basic media (lane 3) or PTC-CM
(lane 4). Extracted RNA was resolved on an agarose/formaldehyde gel,
transferred to a nylon membrane and hybridized to random-primed
32P-laheled cDNA5 for IGFBP-3 and 18S.
increases in both NHE activity and in whole kidney IGF-I mRNA
and protein levels [9, 361.
Although IGFBPs have been clearly recognized as having both
inhibitory and stimulatory effects on IGF-I action in different
experimental settings [30, 311, their role in determining the action
of IGF-I in tubulointerstitial renal disease has not been studied. A
previous study in rats indicated that CF solely express IGFBF-3
mRNA and that FTC exclusively express IGFBP-4 mRNA [37].
However, the present investigation found that human CF
produce and secrete large quantities of both IGFBP-3 and
IGFBP-2, while human FTC synthesize IGFBP-3. Interestingly,
the fate of IGFBP-3 differs between the two human cell popula-
tions in that IGFBP-3 produced by CF is largely secreted, while
PTC IGFBP-3 remains principally cell-associated and is not
released into PTC-CM in detectable quantities. Moreover, the
finding that des(1-3)IGF-1, an IGF-l analog that has a comparable
receptor affinity but markedly decreased affinity for IGFBPs [8],
is significantly less potent than IGF-I in stimulating PTC growth
suggests that cell-associated IGFBP-3 facilitates IGF-I action.
One possible mechanism for this potentiation of IGF-I activity
may involve a lowering of the affinity of PTC-associated IGFBP-3
for IGF-I, thereby promoting its release in the vicinity of the PTC
IGF-I receptor. The association constant (Ka) of cell-associated
IGFBP-3 for IGF-I has previously been shown in bovine fibro-
blasts to be tenfold lower than that of soluble IGFBP-3 and is
nearly equivalent to that of the IGF-I receptor [30]. This finding
is corroborated in human PTC by the observation of linear
Scatchard plots, despite the demonstration by affinity labeling
experiments of two IGF-I-binding sites (that is, cell-associated
IGFBP-3 and the IGF-I receptor).
The release of two different types of IGFBP by CF may also be
important in determining the actions of IGF-I on PTC. This
release is differentially regulated since exposure of CF to
PTC-CM resulted in an increase in IGFBF-3 secretion without
alteration in IGFBF-2 or IGF-I levels. The implications of mod-
ulation of tubulointerstitial IGFBP subtypes for local IGF-I
bioactivity remain to be determined. However, the relatively
greater effects of CF on FTC in coculture compared with condi-
tioned media experiments may partly relate to augmented IGF-I
action on FTC via stimulated CF secretion of IGFBP-3. Since
exposure of PTC to CF-CM was not associated with an increase in
FTC IGFBP-3 mRNA, the increase in PTC-associated IGFBP-3
may represent increased binding of CF-secreted IGFBP-3 to PTC
surfaces.
An advantage of the present experimental protocol is that it is
performed on human cells, which have been shown to reproduce
the in vivo characteristics of human PTC and CF. Prior in situ
hybridization studies in rat kidney have failed to localize IGF-I
mRNA to the cortical interstitium [38]. One possible reason for
the apparent absence of IGF-I production in rat CF, while
significant amounts are manufactured by human cells, could be
that in situ hybridization is a relatively insensitive technique for
detecting IGF-I production in a small population of cells, which
make up less than 4% of the total kidney volume and are evenly
distributed throughout normal renal cortex [2]. Moreover, signif-
icant species differences may exist in the IGF-I/IGFBP axis,
thereby making extrapolations from animal studies to humans
potentially unreliable. Indeed, cellular patterns of IGF-I and
IGF-II gene expression have been reported to differ between rat
and human kidneys [39].
Although CF modulation of PTC growth and function occurred
largely via the IGF-I/IGFBP axis in vitro, tubulointerstitial "cross-
talk" is likely to be more complex in vivo with additional influ-
ences being exerted by an interplay of ambient growth factors [23].
For example, IGF-I and IGFBF production have been shown to
be influenced by a variety of cytokines known to be important in
the response to renal injury, including transforming growth fac-
tor- (TGFI3) [40], angiotensin II [41] and epidermal growth
factor (EGF) [42]. IGF-I in turn has been shown to control the
actions of other growth factors, such as platelet-derived growth
factor (FDGF), basic fibroblast growth factor (bFGF), angioten-
sin II and EGF [43—45].
In conclusion, we have demonstrated that there is a specific
paracrine interaction between CF and FTC, which involves the
IGF-I/IGFBP axis. The production of IGF-I by human CF is
likely to play a key role in the regulation of human proximal
tubule growth and sodium transport. The concomitant release of
IGFBF-3 by CF is subject to reciprocal regulation by FTC and is
associated with an increase in FTC-associated IGFBF-3, which in
turn facilitates the actions of IGF-I. Our studies suggest that the
renal tubulointerstitial IGF-I/IGFBP axis may be an important
pathogenetic factor in the deranged tubulointerstitial growth
found in progressive renal diseases.
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APPENDIX
Abbreviations used in this article are: IGF-I, insulin-like growth fac-
tor-I; PTC, proximal tubule cells; CF, cortical fibroblasts; CF-CM, CF
conditioned media; NHE, sodium-hydrogen exchange; PTC-CM, proximal
tubule cells conditioned media; IGFBP, insulin-like growth factor binding
proteins.
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